Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Inventory (2017 - 2026)

Inspire Medical Systems' Inventory history spans 10 years, with the latest figure at $166.2 million for Q1 2026.

  • On a quarterly basis, Inventory rose 66.69% to $166.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $166.2 million, a 66.69% increase, with the full-year FY2025 number at $145.3 million, up 81.35% from a year prior.
  • Inventory hit $166.2 million in Q1 2026 for Inspire Medical Systems, up from $145.3 million in the prior quarter.
  • Over the last five years, Inventory for INSP hit a ceiling of $166.2 million in Q1 2026 and a floor of $11.9 million in Q4 2022.
  • Historically, Inventory has averaged $64.6 million across 5 years, with a median of $49.0 million in 2024.
  • Biggest five-year swings in Inventory: crashed 31.02% in 2022 and later surged 212.67% in 2024.
  • Tracing INSP's Inventory over 5 years: stood at $11.9 million in 2022, then skyrocketed by 185.08% to $33.9 million in 2023, then surged by 136.44% to $80.1 million in 2024, then soared by 81.35% to $145.3 million in 2025, then increased by 14.41% to $166.2 million in 2026.
  • Business Quant data shows Inventory for INSP at $166.2 million in Q1 2026, $145.3 million in Q4 2025, and $141.8 million in Q3 2025.